On August 5, 2026, under continued media questioning, the pharmaceutical company involved confirmed that a boy in a gene-editing trial at Shanghai Children's Medical Center died in August 2025 from a serious adverse reaction, after the parties involved had concealed the information and not made it public.
Evidence EVIDENCE
Sources 3 · Archived 0
SourceTypeReliabilityLink
李老师不是你老师TG
2026-10-04 00:57 · 🖼 上海一儿童基因编辑试验曝受试者死亡事件：男童接受高剂量治疗后死亡，近一年后公开
First-hand
●●●●●
国内基因编辑临床试验曝出又一例儿童死亡，从事发到披露已过去一年 腾讯新闻
2026-10-09 11:07 · 8 月 5 日，美国生物医药媒体 STAT 称， 中国出现了第二起基因编辑后儿童死亡事件 ：一名男孩在上海一家医院接受针对 杜氏肌营养不良症 的实验性疗法后死亡。
Web Source
●●●●●
又一个孩子死于基因治疗临床试验 虎嗅
2026-10-09 11:07 · 辉大基因针对杜氏肌营养不良的在研基因编辑治疗HG302开展IIT临床试验，2025年8月确认一名高剂量组受试者因AAV诱发严重免疫反应死亡
Web Source
●●●●●
Context CONTEXT
Cause
Not recorded yet
This event
Death of Boy in Gene-Editing Clinical Trial at Shanghai Children's Medical Center Confirmed Nearly a Year Later
2026.08.05 · Reported
Effect
Not recorded yet